L vs LFCR · P/E 14, rev $18.45B vs rev $75.5M
Loews Corp (L) versus Lifecore Biomedical Inc. (LFCR) — a side-by-side from cached financials, not a winner call.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
L currently screens at market cap $22.36B and trailing P/E 13.8. LFCR currently screens at market cap $207.1M.
Not investment advice. Open the L and LFCR stock pages for the full models.
Not investment advice.